Diabetes Discourse

Dr. Simon Heller, a Professor of Clinical Diabetes at the University of Sheffield, discusses glucose-lowering studies and talks about the link between hypoglycemia and thrombosis in patients with diabetes.

Dr. Simon Heller, a Professor of Clinical Diabetes at the University of Sheffield, and honorary consultant physician with the NHS Foundation Trust in the United Kingdom, reflects on the steps we can take to prevent severe hypoglycemia and reduce cardiovascular risk in diabetic patients.

John Anderson joins fellow Diabetes Discourse hosts John Buse and Carol Wysham to explore exciting clinical trial results presented at this year's Scientific Session of the American Diabetes Association.

Dr. John Anderson joins Dr. Michael Greenberg, host of DermConsult, to discuss skin diseases that dermatologists should be aware of in patients with diabetes.

Is there a link between type 2 diabetes and obesity? Dr. Carol Wysham joins Dr. Kristen Nadeau, a Professor of Pediatric Endocrinology at the University of Colorado School of Medicine, to review her research on type 2 diabetes and what it could mean for our patients.

ReachMD host Dr. Carol Wysham discusses what we currently know about hypoglycemia and cardiovascular disease, how to identify patients at risk for severe hypoglycemia, and the strategies and approaches to mitigate risk of hypoglycemia.

Find the full Prescribing Information here.

There are multiple ways to incorporate the use of Qutenza, a topical treatment for painful diabetic peripheral neuropathy of the feet, into practice. Tune in to hear Dr. David M. Simpson, Dr. Jon T. Gertken, and Ms. Stephanie Simon share their best practices for administering Qutenza as well as the management of painful diabetic peripheral neuropathy of the feet.

QUTENZA® is a registered trademark of Averitas Pharma, Inc.
© 2021 Averitas Pharma, Inc. All rights reserved.
M-QZA-US-01-21-0065 June 2021

Dr. Rozalina G. McCoy, an endocrinologist, primary care physician, and a National Institutes of Health-funded health services researcher examines hypoglycemia risk in insulin-treated type 2 diabetic patients and explores strategies to reduce their risk of recurrent hypoglycemia.

Dr. Jason Ng, Clinical Lead of the Diabetes Technology Medical Home Unit at the University of Pittsburgh, shares strategies we can use to help patients with type 2 diabetes can lower their risk of hypoglycemia.

Dr. Charles Turck discusses the pervasiveness of hypoglycemia in adults with type 2 diabetes with Dr. Brian Frier, an Honorary Professor of Diabetes at the University of Edinburgh.